Page 2 Biocon: Latest News and Updates, Top Stories, Videos, Photos About Biocon

Tata Capital Growth To Invest Rs 225 Crore In Biocon Biologics

On Friday, Biocon Ltd said in a stock exchange filing that the board of its subsidiary Biocon Biologics India has approved a primary equity investment by Tata Capital Growth Fund. As per the agreement, Tata Capital will invest Rs 225 crore ...

This Pharma Stock Offered 65% Gains From March Lows

Kiran Mazumdar Shaw led pharma major Biocon since the March lows has reaped 65% gains, implying that if you had invested Rs. 10000 before the lockdown your money now is worth Rs. 16,500. In Monday's trade the stock struck a 52-week ...

Biocon Shares Hit 52-Week High After DCGI Approves Its Drug For COVID-19 Treatment

On Monday, shares of Biocon Ltd surged as much as 9.8 percent to Rs 446.95, its new 52-week high after the drugmaker announced that it has received an emergency use authorisation (EUA) for its monoclonal antibody Itoliuzumab from the Drug Controller ...

4 Stocks In News Today

On global cues, the benchmark indices sank a huge 500 points early trade as coronavirus spread all across has darkened outlook on global economic recovery. Other market drivers are Trump's maiden visit to India as well as GDP data for October-December ...

Biocon Biologics To Come Out With IPO Issue

On Friday, Biocon Chairperson and MD Kiran Mazumdar Shaw told a leading business channel that Biocon Biologics is looking forward to garner as much as $200-300 million via an initial public offer in next 1.5-2 years time. Also, the company ...

Biocon's Q4 Net Profit Spikes 64%; Board Approves 1:1 Bonus Shares

On Thursday, Biocon reported a 64 percent increase in its consolidated net profit to Rs 213.7 crore for the fourth quarter ended March 2019. The Biotechnology major had posted a net profit of Rs 130.4 crore for the corresponding period of ...

Biocon Hits 52-Week High After FDA Nod for Biosimilar Cancer Drug

Biocon Ltd and Mylan N.V collaboration received an approval for their biosimilar pegfilgrastim from the American regulator FDA (US Food and Drug Administration) to sell in the US market. "Fulphila is expected to be the first biosimilar pegfilgrastim available in the ...

Bluechip Pharma Stocks At 52-Week Lows: Should You Buy?

It was a disastrous week for pharma stocks, with some of the bluest names from the space hitting 52-week lows. India's largest pharma company Sun Pharma, saw its shares hit a new 52-week low of Rs 493. The country's second largest ...

Biocon Rallies 5% On Novel Therapy Launch For Hepatitis C

Shares in Biocon surged 5.70 per cent after the company introduced an advanced novel therapy CIMIVIR-L for the treatment of Hepatitis C in India. The stock was last trading higher by 5.70 per cent on the NSE at Rs 567. "The ...

Syngene International IPO: Should You Consider Investing?

Syngene International is a arm of Biotech company Biocon Ltd and has opened for subscription from 27 July, 2015. Syngene is one of the leading India-based contract research organisations (CRO). The company was incorporated as Syngene International Private Limited on November ...

Biocon Shares Rally On Strong Q1 Numbers

Shares of the Biocon rose more than 3 per cent on Friday after the company reported strong set of Q1 numbers. Biocon Ltd on Thursday reported 23 per cent growth in consolidated net profit at Rs 126 crore for the quarter ...

Biocon Q2 Net Flat at Rs 102 crore

Biotechnology major Biocon today reported a flat growth in its consolidated net profit at Rs 102.05 crore for the quarter ended September 30, 2014. The company had posted a net profit after tax and minority interest at Rs 102.15 crore ...

Biocon News